NervGen Pharma announces CEO transition

6 hours ago 1

NervGen Pharma (TSXV:NGEN:CA) announced that chief eexcutive officer Mike Kelly has resigned from his role as director and officer of the company.
Adam Rogers, chair of the board and representative of NervGen's largest shareholder, has been appointed interim CEO.
Source: Press release

Recommended For You